Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) (“SCT”) announced today that Dr. Brett Schonekess, VP Operations, will be presenting at the BioPartnering North America conference in Vancouver, BC at the Open House Presentation session on Monday afternoon. At this session, Dr. Schonekess will be available to outline the company’s progress and partnership opportunities around SCT’s lead program in stroke, NTxTM-265, as well as discuss the other opportunities SCT is pursuing; Schizophrenia, Multiple Sclerosis, and Traumatic Brain Injury to all interested biotechnology and pharmaceutical companies present.
